Heartbeam Inc
NASDAQ:BEAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Heartbeam Inc
NASDAQ:BEAT
|
US |
|
F
|
Fairvest Ltd
JSE:FTA
|
ZA |
|
I
|
IPD Group Ltd
ASX:IPG
|
AU |
|
A
|
Alfa Laval AB
XMUN:AA9
|
SE |
|
DT Midstream Inc
NYSE:DTM
|
US |
|
Valeo SE
OTC:VLEEY
|
FR |
|
D
|
Derichebourg SA
XMUN:PNU
|
FR |
|
PolyPeptide Group AG
SIX:PPGN
|
CH |
|
B
|
Banco Santander SA
XMUN:BSD2
|
ES |
|
I
|
IWG Plc
SWB:IWG
|
CH |
|
I
|
ImmunoGen Inc
XMUN:IMU
|
US |
Wall St Price Targets
BEAT Price Targets Summary
Heartbeam Inc
According to Wall Street analysts, the average 1-year price target for
BEAT is 3.91 USD with a low forecast of 2.525 USD and a high forecast of 5.25 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BEAT's stock price target?
Price Target
3.91
USD
According to Wall Street analysts, the average 1-year price target for
BEAT is 3.91 USD with a low forecast of 2.525 USD and a high forecast of 5.25 USD.